The store will not work correctly when cookies are disabled.
3-(4-chlorophenyl)-2-isobutyl-10-methylpyrimido[4,5-b]quinoline-4,5(3H,10H)-dione
ID: ALA4779641
PubChem CID: 85090323
Max Phase: Preclinical
Molecular Formula: C22H20ClN3O2
Molecular Weight: 393.87
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)Cc1nc2c(c(=O)c3ccccc3n2C)c(=O)n1-c1ccc(Cl)cc1
Standard InChI: InChI=1S/C22H20ClN3O2/c1-13(2)12-18-24-21-19(20(27)16-6-4-5-7-17(16)25(21)3)22(28)26(18)15-10-8-14(23)9-11-15/h4-11,13H,12H2,1-3H3
Standard InChI Key: IWIKPPNCDBOEMO-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
0.9568 -15.0993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9557 -15.9267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6704 -16.3395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6687 -14.6866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3841 -15.0957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3848 -15.9226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1001 -16.3335 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0945 -14.6816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8103 -15.0888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8140 -15.9184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5330 -16.3282 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.2490 -15.9097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2413 -15.0769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5217 -14.6708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0901 -13.8566 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5145 -13.8459 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9466 -14.6587 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6651 -15.0661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3752 -14.6475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3678 -13.8217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6444 -13.4163 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9374 -13.8371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9619 -16.3160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9659 -17.1419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6793 -17.5490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2535 -17.5579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0777 -13.4015 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.1022 -17.1584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 1 0
9 8 1 0
8 5 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
14 9 1 0
8 15 2 0
14 16 2 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
23 24 1 0
24 25 1 0
12 23 1 0
24 26 1 0
20 27 1 0
7 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 393.87 | Molecular Weight (Monoisotopic): 393.1244 | AlogP: 4.09 | #Rotatable Bonds: 3 |
Polar Surface Area: 56.89 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.83 | CX LogD: 4.83 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.49 | Np Likeness Score: -1.02 |
References
1. Luderman KD,Jain P,Benjamin Free R,Conroy JL,Aubé J,Sibley DR,Frankowski KJ. (2021) Development of pyrimidone D1 dopamine receptor positive allosteric modulators., 31 [PMID:33221389] [10.1016/j.bmcl.2020.127696] |